Number of slides
  • CURRENT: STARMER BATTLES CALLS TO RESIGN OVER MANDELSON VETTING

    Starmer battles calls to resign over Mandelson vetting
    Conservatives refuse to accept prime minister’s move to shift blame by sacking top Foreign Office official
    17. april 2026
  • CURRENT: DATA CENTRE DELAYS THREATEN TO CHOKE AI EXPANSION

    Data centre delays threaten to choke AI expansion
    Almost 40% of such builds in US risk hold-ups, including projects tied to Microsoft and OpenAI
    17. april 2026
  • CURRENT: WELCOME TO THE AGE OF HOARDING

    Welcome to the age of hoarding
    As global economic uncertainty mounts, stockpiling is back
    17. april 2026
  • CURRENT: TRUMP'S LEBANON CEASEFIRE TAKES ISRAEL BY SURPRISE

    Trump's Lebanon ceasefire takes Israel by surprise
    Few Israelis see this truce as a way out of the conflict with Hezbollah, the BBC's Lucy Williamson writes.
    16. april 2026
  • CURRENT: SINGER D4VD ARRESTED ON SUSPICION OF MURDERING TEENAGE GIRL

    Singer D4vd arrested on suspicion of murdering teenage girl
    The remains of 14-year-old Celeste Rivas Hernandez were found in the singer's car last year.
    17. april 2026
  • CURRENT: FINANCE MINISTERS AND TOP BANKERS RAISE SERIOUS CONCERNS ABOUT MYTHOS AI MODEL

    Finance ministers and top bankers raise serious concerns about Mythos AI model
    Experts say Mythos potentially has an unprecedented ability to identify and exploit cybersecurity weaknesses.
    17. april 2026
  • CURRENT: LEO PHARMA FÅR GODKENDT PSORIASISMIDDEL I KINA

    Leo Pharma får godkendt psoriasismiddel i Kina

    Dermatologiselskabet vil lancere Enstilar senere i år. Det sker efter ti år uden lanceringer på det kinesiske marked, hvor Leo Pharma har oplevet modvind det seneste år.

    Medicinal & Biotek
    17. april 2026
  • CURRENT: NOVO NORDISKS WEGOVY-TABLET FORTSÆTTER FREM

    Novo Nordisks Wegovy-tablet fortsætter frem

    Det er, selvom Eli Lillys konkurrerende vægttabstablet er lanceret i USA. 

    Resultater
    17. april 2026
  • CURRENT: "INGEN FREE RIDE": LIF-CHEF KLAR TIL, AT INDUSTRIEN DELER RISIKOEN FOR NYE LÆGEMIDLER

    "Ingen free ride": Lif-chef klar til, at industrien deler risikoen for nye lægemidler

    Lif vil bidrage med løsningsforslag, men kræver også større villighed til at investere i innovation og forandringer i Medicinrådets model. Industrien er klar til risikodeling, hvis rammerne ændres.

    Medicinal & Biotek
    17. april 2026